Apex Institute of Ayurveda with a 200 beded hospital being set up in Delhi.

The Government has approved establishment of All India Institute of Ayurveda at Sarita Vihar, New Delhi. The Institute has been conceived as an Apex Institute of Ayurveda with 200 bedded referral hospital for imparting education in the field of Ayurveda at M.D. and Ph.D level. The construction activities and procurement of medical equipment and furniture are at an advanced stage of completion. 

Research and Development in AYUSH is undertaken in accordance with the objectives and strategies outlined in the ‘National Policy for Indian Systems of Medicine and Homoeopathy-2002’. Central Government has set up Research Councils and implemented a Central Scheme of Extramural Research to undertake and support research & development activities including development of drugs in Ayurveda, Siddha, Unani and Homoeopathy. 80 units of the four Research Councils are functioning in the country. Adequate resources are provided to these initiatives inter-alia to facilitate development and discovery of such drugs, which are different from the classical formulations mentioned in the authoritative books. Drugs & Cosmetics Act, 1940 has a provision for patent or proprietary medicines in relation to Ayurvedic, Siddha and Unani systems of medicine. Many such medicines are licensed and available in the market. Rule 158-B of the Drugs & Cosmetics Rules, 1945 provides inter-alia the regulatory guidelines for the evidence of safety and effectiveness requirements for licensing of new formulations and Ayurvedic, Siddha and Unani drugs with new indications. Government has also published Good Clinical Practice guidelines for imparting technical assistance in the area of research and development of AYUSH drugs for the conduct of clinical trials.